Further, we examined EPO-induced JAK2/STAT5 survival signaling in the NSCLC cell line H838 and its derivative H838-HA-hEPOR because it had been reported that EPO induces survival signaling via the JAK2/STAT5 pathway in CFU-E cells [19]. Here, STAT5B is linked to non-small cell lung carcinoma.